Incorporation of 5-methylcytidine alleviates RIG-I–mediated innate immune responses to a self-amplifying RNA vaccine

Journal:

Science Translational Medicine

Published:

2025-11-12

DOI:

10.1126/scitranslmed.adz2276

Affiliations:

3

Authors:

20

Go to article

Institutions	Authors	Share
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	8.000000	0.40
VLP Therapeutics, LLC, United States of America (USA)	7.000000	0.35
Boston Medical Center (BMC), United States of America (USA)	5.000000	0.25

Interested in Medical Biotechnology?